GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan · Delayed Price · Currency is TWD 44.85
+0.05 (0.11%)
Jan 22, 2026, 1:30 PM CST
GeneFerm Biotechnology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 16.07 | -22.53 | 124.62 | 93.45 | 57.41 | 4.53 | Upgrade |
Depreciation & Amortization | 75.71 | 79.36 | 73.49 | 50.03 | 45.36 | 41.07 | Upgrade |
Loss (Gain) From Sale of Assets | 0.26 | -0.02 | -0.01 | 0.11 | -0.04 | -0.43 | Upgrade |
Stock-Based Compensation | - | - | - | - | - | 1.53 | Upgrade |
Provision & Write-off of Bad Debts | 0.43 | -1.09 | -0.43 | -0.72 | 1.44 | 0.93 | Upgrade |
Other Operating Activities | -0.17 | -34.31 | 5.11 | 1.06 | 24.97 | 6.82 | Upgrade |
Change in Accounts Receivable | -0.43 | 11.92 | -6.86 | 4.51 | -33.4 | -3.23 | Upgrade |
Change in Inventory | -4.85 | -15.47 | -9.38 | -30.94 | -8.14 | -7.83 | Upgrade |
Change in Accounts Payable | 12.48 | 3.94 | -3.23 | 0.19 | -0.43 | 9.4 | Upgrade |
Change in Unearned Revenue | 7.95 | 6.71 | -1.85 | -0.67 | 1.33 | 3.97 | Upgrade |
Change in Other Net Operating Assets | -2.05 | -20.42 | 8.85 | 5.4 | 23.72 | -0.33 | Upgrade |
Operating Cash Flow | 105.4 | 8.09 | 190.31 | 122.43 | 112.23 | 56.42 | Upgrade |
Operating Cash Flow Growth | 301.49% | -95.75% | 55.44% | 9.09% | 98.93% | 485.26% | Upgrade |
Capital Expenditures | -20 | -22.4 | -69.94 | -278.18 | -144.88 | -82.32 | Upgrade |
Sale of Property, Plant & Equipment | 0.23 | 0.03 | 0.01 | 0.04 | 0.04 | 0.43 | Upgrade |
Sale (Purchase) of Intangibles | - | -0.3 | -1.46 | -0.24 | -0.72 | - | Upgrade |
Other Investing Activities | 0.78 | -0.16 | 0.78 | -1.95 | 0.31 | -0.15 | Upgrade |
Investing Cash Flow | -19 | -22.83 | -70.62 | -280.33 | -145.26 | -82.04 | Upgrade |
Short-Term Debt Issued | - | 80 | 240 | 45 | - | - | Upgrade |
Long-Term Debt Issued | - | 171 | - | - | 5 | 20 | Upgrade |
Total Debt Issued | 160 | 251 | 240 | 45 | 5 | 20 | Upgrade |
Short-Term Debt Repaid | - | -120 | -245 | - | - | -20 | Upgrade |
Long-Term Debt Repaid | - | -31.7 | -32.68 | -285.33 | -74.17 | -53.06 | Upgrade |
Total Debt Repaid | -106.75 | -151.7 | -277.68 | -285.33 | -74.17 | -73.06 | Upgrade |
Net Debt Issued (Repaid) | 53.25 | 99.3 | -37.68 | -240.33 | -69.17 | -53.06 | Upgrade |
Issuance of Common Stock | - | - | - | - | 297.36 | - | Upgrade |
Common Dividends Paid | - | -82.92 | -62.19 | -41.46 | -3.39 | - | Upgrade |
Financing Cash Flow | 53.25 | 16.38 | -99.87 | -281.79 | 224.81 | -53.06 | Upgrade |
Foreign Exchange Rate Adjustments | -1 | 0.65 | -0.36 | 0.76 | -0.19 | 0.41 | Upgrade |
Net Cash Flow | 138.65 | 2.3 | 19.46 | -438.92 | 191.59 | -78.27 | Upgrade |
Free Cash Flow | 85.39 | -14.31 | 120.37 | -155.74 | -32.65 | -25.9 | Upgrade |
Free Cash Flow Growth | 1483.72% | - | - | - | - | - | Upgrade |
Free Cash Flow Margin | 13.04% | -2.74% | 15.17% | -24.57% | -6.25% | -7.03% | Upgrade |
Free Cash Flow Per Share | 2.06 | -0.34 | 2.89 | -3.66 | -0.70 | -0.93 | Upgrade |
Cash Interest Paid | 5.83 | 4.42 | 4.15 | 2.74 | 1.23 | 3.65 | Upgrade |
Cash Income Tax Paid | 0.13 | 34.43 | 20.28 | 20.86 | -1.97 | 0 | Upgrade |
Levered Free Cash Flow | 80.32 | -14.32 | 67.65 | -169.4 | -49.01 | -37.47 | Upgrade |
Unlevered Free Cash Flow | 84 | -11.55 | 70.26 | -167.01 | -44.44 | -31.33 | Upgrade |
Change in Working Capital | 13.1 | -13.32 | -12.47 | -21.5 | -16.91 | 1.98 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.